up to now number of years, the united kingdom has witnessed a revolution in clinical bodyweight‑reduction treatment options — with the introduction of semaglutide (Wegovy®) into the growing level of popularity of tirzepatide (Mounjaro®). Now, One more name is drawing interest in equally medical a